Fadıl ÖZYENER, Serdar ŞAHİNTÜRK, Naciye İŞBİL, Sadettin DEMİREL

Irisin relaxes rat thoracic aorta through inhibiting signaling pathways implicating protein kinase C

Background/aim: Irisin, a newly identified exercise-derived myokine, has been found involved in a peripheral vasodilator effect. However, little is known regarding the potential vascular activity of irisin, and the mechanisms underlying its effects on vascular smooth muscle have not been fully elucidated. This study was aimed to investigate the effects of irisin on vascular smooth muscle contractility in rat thoracic aorta, and the hypothesis that protein kinase C (PKC) may have a role in these effects. Materials and methods: Isometric contraction-relaxation responses of thoracic aorta rings were measured with an isolated organ bath model. The steady contraction was induced with 10 µM phenylephrine (PHE), and then the concentration-dependent responses of irisin (0.001-1 µM) were examined. The time-matched vehicle control (double distilled water) group was also formed. To evaluate the role of PKC, endothelium-intact thoracic aorta rings were incubated with 150 nM bisindolylmaleimide I (BIM I) for 20 min before the addition of 10 µM PHE and irisin. Also, a vehicle control group was formed for dimethyl sulfoxide (DMSO). Results: Irisin exerted the vasorelaxant effects at concentrations of 0.01, 0.1, and 1 µM compared to the control group (p < 0.001). Besides, PKC inhibitor BIM I incubation significantly inhibited the relaxation responses induced by varying concentrations of irisin (p: 0.000 for 0.01 µM; p: 0.000 for 0.1 µM; p: 0.000 for 1 µM). However, DMSO, a solvent of BIM I, did not modulate the relaxant effects of irisin (p > 0.05). Conclusion: In conclusion, physiological findings were obtained regarding the functional relaxing effects of irisin in rat thoracic aorta. The findings demonstrated that irisin induces relaxation responses in endothelium-intact thoracic aorta rings in a concentration-dependent manner. Furthermore, this study is the first to report that irisin-induced relaxation responses are regulated probably via activating signaling pathways implicating PKC.

PDF

___

1. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L et al. A PGC1- α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-468. doi: 10.1038/nature10777
2. Sanchis-Gomar F, Lippi G, Mayero S, Perez-Quilis C, GarcíaGiménez JL. Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. Journal of Diabetes, 2012; 4: 196. doi: 10.1111/j.1753-0407.2012.00194.x
3. Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Makras P, Perakakis N et al. Irisin in metabolic diseases. Endocrine 2018; 59: 260-274. doi: 10.1007/s12020-017-1476-1
4. Korta P, Pocheć E, Mazur-Biały A. Irisin as a multifunctional protein: implications for health and certain diseases. Medicina (Kaunas) 2019; 55: 485. doi: 10.3390/medicina55080485
5. Ma C, Ding H, Deng Y, Liu H, Xiong X et al. Irisin: a new code uncover the relationship of skeletal muscle and cardiovascular health during exercise. Frontiers in Physiology 2021; 12: 620608. doi: 10.3389/fphys.2021.620608
6. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Journal of Hypertension 2005; 23: 233-246. doi: 10.1097/00004872-200502000-00001
7. Jespersen B, Tykocki NR, Watts SW, Cobbett PJ. Measurement of smooth muscle function in the isolated tissue bath-applications to pharmacology research. Journal of Visualized Experiments 2015; 19: 52324. doi: 10.3791/52324
8. Maciorkowska M, Musiałowska D, Małyszko J. Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease. Advances in Clinical and Experimental Medicine 2019; 28: 1571-1575. doi: 10.17219/acem/104551
9. Byun K, Lee S. The potential role of irisin in vascular function and atherosclerosis: a review. International Journal of Molecular Sciences 2020; 21: 7184. doi: 10.3390/ijms21197184
10. Voutyritsa E, Kyriakos G, Patsouras A, Damaskos C, Garmpi A et al. Experimental agents for the treatment of atherosclerosis: new directions. Journal of Experimental Pharmacology 2021; 13: 161-179. doi: 10.2147/JEP.S265642
11. Pedersen BK, Akerström TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. Journal of Applied Physiology 2007; 103: 1093-1098. doi: 10.1152/ japplphysiol.00080.2007
12. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology 2012; 8: 457-465. doi: 10.1038/nrendo.2012.49
13. Strasser B. Physical activity in obesity and metabolic syndrome. Annals of the New York Academy of Sciences 2013; 1281: 141- 159. doi: 10.1111/j.1749-6632.2012.06785.x
14. Demirel S, Şahintürk S, Özyener F. Irisin and its effects on vascular contractility. Medical Journal of Suleyman Demirel University 2021; 28: 163-170. doi: 10.17343/sdutfd.718412
15. Zhang W, Chang L, Zhang C, Zhang R, Li Z et al. Central and peripheral irisin differentially regulate blood pressure. Cardiovascular Drugs and Therapy 2015; 29: 121-127. doi: 10.1007/s10557-015-6580-y
16. Han F, Zhang S, Hou N, Wang D, Sun X. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. American Journal of Physiology-Heart and Circulatory 2015; 309: H1501-H1508. doi: 10.1152/ajpheart.00443.2015
17. Jiang M, Wan F, Wang F, Wu Q. Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endotheliumindependent mechanisms. Biochemical and Biophysical Research Communications 2015; 468: 832-836. doi: 10.1016/j. bbrc.2015.11.040
18. Fu J, Han Y, Wang J, Liu Y, Zheng S et al. Irisin lowers blood pressure by improvement of endothelial dysfunction via AMPK-Akt-eNOS-NO pathway in the spontaneously hypertensive rat. Journal of the American Heart Association 2016; 5: e003433. doi: 10.1161/JAHA.116.003433
19. Hou N, Liu Y, Han F, Wang D, Hou X et al. Irisin improves perivascular adipose tissue dysfunction via regulation of the heme oxygenase-1/adiponectin axis in diet-induced obese mice. Journal of Molecular and Cellular Cardiology 2016; 99: 188-196. doi: 10.1016/j.yjmcc.2016.09.005
20. Ye L, Xu M, Hu M, Zhang H, Tan X et al. TRPV4 is involved in irisin-induced endothelium-dependent vasodilation. Biochemical and Biophysical Research Communications 2017; 495: 41-45. doi: 10.1016/j.bbrc.2017.10.160
21. Cosentino-Gomes D, Rocco-Machado N, Meyer-Fernandes JR. Cell signaling through protein kinase C oxidation and activation. International Journal of Molecular Sciences 2012; 13: 10697-10721. doi: 10.3390/ijms130910697
22. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiological Reviews 2003; 83: 1325- 1258. doi: 10.1152/physrev.00023.2003
23. Massett MP, Ungvari Z, Csiszar A, Kaley G, Koller A. Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. American Journal of Physiology-Heart and Circulatory 2002; 283: H2282-H2287. doi: 10.1152/ ajpheart.00544.2002
24. Korzick DH, Laughlin MH, Bowles DK. Alterations in PKC signalling underlie enhanced myogenic tone in exercisetrained porcine coronary resistance arteries. Journal of Applied Physiology 2004; 96: 1425-1432. doi: 10.1152/ japplphysiol.01077.2003
25. Soloviev AI, Kizub IV. Mechanisms of vascular dysfunction evoked by ionizing radiation and possible targets for its pharmacological correction. Biochemical Pharmacology 2018; 159: 121-139. doi: 10.1016/j.bcp.2018.11.019
26. Zhu D, Wang H, Zhang J, Zhang X, Xin C et al. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. Journal of Molecular and Cellular Cardiology 2015; 87: 138-147. doi: 10.1016/j.yjmcc.2015.07.015
27. Partovian C, Zhuang Z, Moodie K, Lin M, Ouchi N et al. PKCalpha activates eNOS and increases arterial blood flow in vivo. Circulation Research 2005; 97: 482-487. doi: 10.1161/01. RES.0000179775.04114.45
28. Wang Y, Zhou H, Wu B, Zhou Q, Cui D et al. Protein kinase C isoforms distinctly regulate propofol-induced endotheliumdependent and endothelium-independent vasodilation. Journal of Cardiovascular Pharmacology 2015; 66: 276-284. doi: 10.1097/FJC.0000000000000275
29. Clark SG, Fuchs LC. Role of nitric oxide and Ca++-dependent K+ channels in mediating heterogeneous microvascular responses to acetylcholine in different vascular beds. Journal of Pharmacology and Experimental Therapeutics 1997; 282: 1473-1479. PMID: 9316861
30. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiological Reviews 1990; 70: 921-961. doi: 10.1152/ physrev.1990.70.4.921
31. de Wit C, Wölfle SE. EDHF and gap junctions: important regulators of vascular tone within the microcirculation. Current Pharmaceutical Biotechnology 2007; 8: 11-25. doi: 10.2174/138920107779941462